Alembic Pharmaceuticals acquires Orit Laboratories LLC

01 Nov 2017 Evaluate

Alembic Pharmaceuticals through its 100% owned subsidiary, Alembic Pharmaceuticals Inc., has completed acquisition of West Caldwell, New Jersey, USA based generic drug developer Orit Laboratories LLC (Orit) along with real estate, owned by Okner Realty LLC (Okner).

The acquisition increases Alembic’s US product portfolio with 7 approved ANDAs, and 4 ANDAs pending approval. The acquisition also increases Alembic’s breadth and capabilities in the US with a competent R&D team bringing complementary skill sets in soft-gelatin based oral solids and oral liquids.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907.


Alembic Pharma Share Price

775.30 -13.90 (-1.76%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×